Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ae Nim Pae

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
European Journal of Medicinal Chemistry|August 14, 2018
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's diseaseJi Woong Lim, Seok Kyu Kim, Seo Yun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressantSuk Youn Kang, Eun-Jung Park, Woo-Kyu Park, et al.
Chemmedchem|January 26, 2016
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis OpticaEun Ji Ju, Seul Ki Yeon, Jong-Hyun Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 16, 2023
Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressantsElliot H Lee, Jung-Eun Park, Lizaveta Gotina, et al.
Communications Biology|January 22, 2020
CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individualYeomin Yun, Sung-Ah Hong, Ka-Kyung Kim, et al.
Experimental & Molecular Medicine|March 14, 2023
Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau<sup>P301L</sup>-BiFC miceSungsu Lim, Seulgi Shin, Yoonsik Sung, et al.
Signal Transduction and Targeted Therapy|August 22, 2025
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseasesWoojin Won, Elijah Hwejin Lee, Lizaveta Gotina, et al.
Theranostics|October 21, 2024
Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's diseaseHyeon Jeong Kim, Haelee Kim, Jaeyoung Song, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
European Journal of Medicinal Chemistry|August 14, 2018
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's diseaseJi Woong Lim, Seok Kyu Kim, Seo Yun Choi, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2010
Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressantSuk Youn Kang, Eun-Jung Park, Woo-Kyu Park, et al.
Chemmedchem|January 26, 2016
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis OpticaEun Ji Ju, Seul Ki Yeon, Jong-Hyun Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 16, 2023
Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressantsElliot H Lee, Jung-Eun Park, Lizaveta Gotina, et al.
Communications Biology|January 22, 2020
CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individualYeomin Yun, Sung-Ah Hong, Ka-Kyung Kim, et al.
Experimental & Molecular Medicine|March 14, 2023
Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau<sup>P301L</sup>-BiFC miceSungsu Lim, Seulgi Shin, Yoonsik Sung, et al.
Signal Transduction and Targeted Therapy|August 22, 2025
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseasesWoojin Won, Elijah Hwejin Lee, Lizaveta Gotina, et al.
Theranostics|October 21, 2024
Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's diseaseHyeon Jeong Kim, Haelee Kim, Jaeyoung Song, et al.
Science Advances|March 26, 2019
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's diseaseJong-Hyun Park, Yeon Ha Ju, Ji Won Choi, et al.
Pageof 18